Book Value per Share: scPharmaceuticals, Inc. (SCPH)

Graphic logo of scPharmaceuticals (SCPH)

The daily price chart for scPharmaceuticals Inc. (SCPH) reflects the performance of the company developing drug delivery systems. The indicator stands at -0.40. The business relies on patents for subcutaneous administration of cardiac medications, which creates high barriers to entry for competitors due to stringent FDA requirements. Risks include logistical disruptions and geopolitical tensions complicating international certification. Protection against replication has been strengthened by the success of the Furoscix patch, which reduces hospital expenses.

scPharma (SCPH): Share Book Value from 07/04/2022 to 10/18/2025
Manufactured products of scPharma

The commercialization of FUROSCIX for the treatment of heart failure determines the financial stability of scPharmaceuticals Inc. (SCPH), as clearly reflected in the book value per share chart. This indicator is calculated as the ratio of equity to the number of issued shares, allowing investors to assess the real value of net assets and identify risks of share dilution or asset impairment.

Competitors of scPharmaceuticals Inc. (SCPH)

Net Assets per Single Share Haleon Group|KVUE - Share Book Value|Book Value per Share Verona Pharma plc VRNA|MENS (jyongbio.com) - Accounting Value of a Share|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value per Share|Accounting Value of a Share Alvotech Biopharmaceuticals (ALVO)|Book Value per Share LQDA (Liquidia Corporation)|glpg.com - Book Value per Share|Net Assets per Single Share ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Accounting Value of a Share|AMPH (Amphastar) - Net Assets per Single Share|Pacira Corp (PCRX) - Accounting Value per Share|SPRY (ARS Pharmaceuticals) - Book Value per Share|Book Value per Share theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Accounting Value per Share|Accounting Value of a Share TECX (tectonictx.com)|TNXP: Net Assets per Single Share|SXTC - Net Asset Value per Share|Accounting Value per Share Eupraxia Pharma EPRX|BHST - Book Price of a Share|Book Value per Share eXoZymes EXOZ|Oramed Pharmaceuticals Inc. (ORMP) - Accounting Value of a Share|Book Value per Share ENTX (Entera Bio Ltd)|Net Asset Value per Share HYFT|ABVC BioPharma (ABVC) - Net Assets per Single Share|Accounting Value of a Share CPIX (cumberlandpharma.com)|Net Assets per Single Share QNTM|Net Assets per Share FibroGen Inc FGEN|TELO: Book Value per Share|RANI: Accounting Value per Share|Net Assets per Single Share synergychc.com (SNYR)|Rallybio (RLYB) - Share Book Value|LEXX - Book Value per Share|Accounting Value of a Share Pulmatrix Inc|Book Value per Share PTHL|Book Value per Share APM (aptorumgroup.com)|Net Assets per Single Share Lyra Therapeutics, Inc.|Impact BioMedical, Inc. - Accounting Value of a Share|TNFA: Net Assets per Single Share|YCBD - Accounting Value per Share|PRFX: Book Value per Share|Altamira Therapeutics Ltd. (CYTO) - Book Value per Share|Book Value per Share LIPO|Accounting Value per Share optinose.com|Pieris Pharmaceuticals, Inc. - Book Value per Share|Net Asset Value per Share Procaps Group PROC|Accounting Value per Share PTPI (Petros)|QLI - Book Value per Share|Accounting Value per Share Acelyrin, Inc. SLRN|TFFP - Book Price of a Share